核素法前哨淋巴结活检术在T_(1-2)N_0M_0乳腺癌中的应用  

Application of Nucleinotherapy Sentinel Lymph Node Biopsy to the Treatment of T_(1-2)N_0M_0 Breast Cancer

作　　者：郭繁[1] 于明江[2] 

机构地区：[1]山西省肿瘤医院,山西太原030013 [2]山西职工医学院,山西太原030012

出　　处：《山西职工医学院学报》2010年第3期4-6,共3页Journal of Shanxi Medical College for Continuing Education

摘　　要：目的:探讨核素法前哨淋巴结活检术(SLNB)在T1-2N0M0乳腺癌治疗中的准确性和可行性。方法:选取2006年1月至2007年4月的43例T1-2N0M0乳腺癌患者,使用核素法行SLNB,随后行包括腋窝淋巴结清扫(ALND)在内的根治性手术,统计相关数据,分析SLNB相关影响因素。结果:SLNB成功率97.7%,假阴性率18.25%,准确率92.9%。患者年龄小于50岁、原发乳腺肿瘤部位、操作者的学习曲线与前哨淋巴结(SLN)检出率有明显相关性,肿瘤大小、病理类型与SLN检出率无明显相关性。结论:核素法SLNB是一项可行的技术,可提高乳腺癌检出率,降低假阴性率。Objective： To investigate the accuracy and feasibility of nucleinotherapy sentinel lymph node biopsy（SLNB） in treatment of T1-2 N0M0 breast cancer.Methods： Forty-three patients with T1-2 N0M0 breast cancer from January 2006 to April 2007 were chosen to be performed sentinel lymph node biopsy by nucleinotherapy and then carried out radical operation including axillary lymph node dissection（ALND） so as to count up the relative data and analyze the relative influenced factors.Results： The successful rate,false positive rate and the accurate rate of SLNB were 97.7%,18.25%and 92.9% respectively.There was obvious correlation in the following such as the ages of patients（under 50）,primary site of breast carcinoma,the proficiency in operating of qualified operators and the detection rate of sentinel lymph node but there was no obvious correlation in tumor size,the pathology type and the detection rate of sentinel lymph node.Conclusion： Nucleinotherapy SLNB is a feasible technology and it could improve the detection rate and reduce the false positive rate.

关 键 词：乳腺癌 前哨淋巴结 核素法 

分 类 号：R817.4[医药卫生—影像医学与核医学]